Parallel Traders Slam Czech Plan For List Of Non-Exportable Drugs
European parallel traders are unhappy with a Czech government proposal to draw up a list of “irreplaceable” medicines that are subject to restrictions on re-exportation.
You may also be interested in...
An amendment to the Medicines Act designed to limit distributors’ ability to parallel export medicines to higher priced EU markets has been signed, but some lawyers argue it might not be fit for purpose.
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.